BBK Worldwide Blog

Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.

BBK's Clinical Cuisine™ was just selected as one of the most innovative products of 2022 by PM360, a leading industry publication for the pharmaceutical, biotech, medical device and diagnostics industries.

A first-of-its-kind service, Clinical Cuisine helps support patients and caregivers during clinical trial participation by removing the burden of meal planning and preparation.

According to the Centers for Disease Control and Prevention (CDC), among the top ten leading causes of death in the United States per year are diseases that include heart disease (696,962), cancer (602,350), stroke (160,264), Alzheimer’s disease (134,242) and diabetes (102,188).¹ It makes sense, then, that there would be substantial clinical efforts to provide preventative and curative treatments for these conditions. However, when planning your trial to test the efficacy of your treatment, how often do you reflect on the actual patient population?

The Necessity of Diverse and Inclusive Clinical Trials – And How to Get There*

Marginalized populations continue to be underrepresented in clinical trials — hurting both the relevance of scientific results and the quest for health equity. What can be done to overcome the mistrust many in these communities feel towards medical research, and to ensure they become fully invested participants in clinical trials?

Click here to read the full article in International Clinical Trials.

*Taken from International Clinical Trials, Autumn 2022, pages 16-20. © Samedan Ltd

In the September issue of PM360, Rob Laurens joins other industry thought leaders to share their opinions on what it takes today for life sciences companies to practice a patient-first approach.

BBK's patient recruitment campaign for Parkinson's disease has been selected as a finalist for the Pharmaceutical Executive APEX Awards

It's exciting times here at BBK! We are so thrilled to be recognized for our creative work on the Cerevel TemPo Studies website; developed to inform and prescreen patients newly diagnosed with Parkinson’s disease. We've been selected as a finalist for this year’s Pharmaceutical Executive APEX Awards — the only healthcare marketing awards judged entirely by HCPs. 

The Impact of the EU Clinical Trials Regulation on Patient Recruitment Planning

The EU Clinical Trials Regulation (CTR) replaces the Clinical Trials Directive 2001 / 20 / EC and looks to ensure a unified set of rules for the conduct of clinical trials throughout the European Union. From the outset, policymakers had the aim of making the EU more attractive to clinical trials by simplifying submissions, authorizations and conduct among EU member states, thereby also offering greater transparency into trial data.

Catch Up on Our Content for Clinical Trial Sponsors

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial patient recruitment and engagement environment.

Hear From Our Experts on Improving Clinical Trial Enrollment Diversity

In our latest podcast, BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors can leverage to make their studies more diverse and inclusive.  

Introducing a New Approach to Clinical Trial Recruitment & Engagement

Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial.